226 related articles for article (PubMed ID: 18212124)
1. Generation of biologically contained Ebola viruses.
Halfmann P; Kim JH; Ebihara H; Noda T; Neumann G; Feldmann H; Kawaoka Y
Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1129-33. PubMed ID: 18212124
[TBL] [Abstract][Full Text] [Related]
2. Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription.
Takamatsu Y; Krähling V; Kolesnikova L; Halwe S; Lier C; Baumeister S; Noda T; Biedenkopf N; Becker S
mBio; 2020 Feb; 11(1):. PubMed ID: 32098814
[TBL] [Abstract][Full Text] [Related]
3. Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription.
Ilinykh PA; Tigabu B; Ivanov A; Ammosova T; Obukhov Y; Garron T; Kumari N; Kovalskyy D; Platonov MO; Naumchik VS; Freiberg AN; Nekhai S; Bukreyev A
J Biol Chem; 2014 Aug; 289(33):22723-22738. PubMed ID: 24936058
[TBL] [Abstract][Full Text] [Related]
4. Role of VP30 phosphorylation in the Ebola virus replication cycle.
Martinez MJ; Volchkova VA; Raoul H; Alazard-Dany N; Reynard O; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S934-40. PubMed ID: 21987772
[TBL] [Abstract][Full Text] [Related]
5. An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.
Li D; Chen T; Hu Y; Zhou Y; Liu Q; Zhou D; Jin X; Huang Z
J Virol; 2016 Oct; 90(19):8720-8. PubMed ID: 27440895
[TBL] [Abstract][Full Text] [Related]
6. Generation of vero cells expressing ebola virus glycoprotein.
Makino A; Kawaoka Y
J Vet Med Sci; 2009 Apr; 71(4):505-7. PubMed ID: 19420858
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle.
Martin S; Chiramel AI; Schmidt ML; Chen YC; Whitt N; Watt A; Dunham EC; Shifflett K; Traeger S; Leske A; Buehler E; Martellaro C; Brandt J; Wendt L; Müller A; Peitsch S; Best SM; Stech J; Finke S; Römer-Oberdörfer A; Groseth A; Feldmann H; Hoenen T
Genome Med; 2018 Aug; 10(1):58. PubMed ID: 30081931
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription.
Tigabu B; Ramanathan P; Ivanov A; Lin X; Ilinykh PA; Parry CS; Freiberg AN; Nekhai S; Bukreyev A
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135121
[TBL] [Abstract][Full Text] [Related]
9. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
10. Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle.
Biedenkopf N; Lier C; Becker S
J Virol; 2016 May; 90(10):4914-4925. PubMed ID: 26937028
[TBL] [Abstract][Full Text] [Related]
11. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
Nelson EV; Pacheco JR; Hume AJ; Cressey TN; Deflubé LR; Ruedas JB; Connor JH; Ebihara H; Mühlberger E
Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
[TBL] [Abstract][Full Text] [Related]
12. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
Hartman AL; Dover JE; Towner JS; Nichol ST
J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
[TBL] [Abstract][Full Text] [Related]
13. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication.
Reynard O; Nguyen XN; Alazard-Dany N; Barateau V; Cimarelli A; Volchkov VE
Viruses; 2015 Dec; 7(12):6233-40. PubMed ID: 26633464
[TBL] [Abstract][Full Text] [Related]
14. Replication-deficient ebolavirus as a vaccine candidate.
Halfmann P; Ebihara H; Marzi A; Hatta Y; Watanabe S; Suresh M; Neumann G; Feldmann H; Kawaoka Y
J Virol; 2009 Apr; 83(8):3810-5. PubMed ID: 19211761
[TBL] [Abstract][Full Text] [Related]
15. RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.
Biedenkopf N; Schlereth J; Grünweller A; Becker S; Hartmann RK
J Virol; 2016 Aug; 90(16):7481-7496. PubMed ID: 27279615
[TBL] [Abstract][Full Text] [Related]
16. Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide.
Hartlieb B; Modrof J; Mühlberger E; Klenk HD; Becker S
J Biol Chem; 2003 Oct; 278(43):41830-6. PubMed ID: 12912982
[TBL] [Abstract][Full Text] [Related]
17. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.
Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S941-6. PubMed ID: 21987773
[TBL] [Abstract][Full Text] [Related]
18. Development of a New Reverse Genetics System for Ebola Virus.
Gan T; Zhou D; Huang Y; Xiao S; Ma Z; Hu X; Tong Y; Yan H; Zhong J
mSphere; 2021 May; 6(3):. PubMed ID: 33952663
[TBL] [Abstract][Full Text] [Related]
19. The Ebola Virus Nucleoprotein Recruits the Host PP2A-B56 Phosphatase to Activate Transcriptional Support Activity of VP30.
Kruse T; Biedenkopf N; Hertz EPT; Dietzel E; Stalmann G; López-Méndez B; Davey NE; Nilsson J; Becker S
Mol Cell; 2018 Jan; 69(1):136-145.e6. PubMed ID: 29290611
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of filovirus replication by the zinc finger antiviral protein.
Müller S; Möller P; Bick MJ; Wurr S; Becker S; Günther S; Kümmerer BM
J Virol; 2007 Mar; 81(5):2391-400. PubMed ID: 17182693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
